Related references
Note: Only part of the references are listed.The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models
Pall Thor Ingvarsson et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Formulation and Characterization of Nanoemulsion Intranasal Adjuvants: Effects of Surfactant Composition on Mucoadhesion and Immunogenicity
Pamela T. Wong et al.
MOLECULAR PHARMACEUTICS (2014)
Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus
Wenqian Tao et al.
NANOMEDICINE (2014)
Pathogenic potential of interferon αβ in acute influenza infection
Sophia Davidson et al.
NATURE COMMUNICATIONS (2014)
Drug/polymer nanoparticles prepared using unique spray nozzles and recent progress of inhaled formulation
Tetsuya Ozeki et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection
Jamie F. S. Mann et al.
JOURNAL OF CONTROLLED RELEASE (2013)
The Possible Proton Sponge Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH
Rikke V. Benjaminsen et al.
MOLECULAR THERAPY (2013)
Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery
Nitesh K. Kunda et al.
PHARMACEUTICAL RESEARCH (2013)
Effects of different CpG oligodeoxynucleotides with inactivated avian H5N1 influenza virus on mucosal immunity of chickens
Jia Fu et al.
POULTRY SCIENCE (2013)
Mechanisms of action of adjuvants
Sunita Awate et al.
FRONTIERS IN IMMUNOLOGY (2013)
Vaccines against mucosal infections
Jan Holmgren et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Technologies for enhanced efficacy of DNA vaccines
Fadi Saade et al.
EXPERT REVIEW OF VACCINES (2012)
Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy
Juliana De Souza Reboucas et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
Aseem Pandey et al.
PLOS ONE (2012)
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Natasha Kushnir et al.
VACCINE (2012)
Mucosal vaccination: Lung versus nose
Ana Vujanic et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2012)
Vaccines: From Empirical Development to Rational Design
Christine Rueckert et al.
PLOS PATHOGENS (2012)
Progress in developing spray-drying methods for the production of controlled morphology particles: From the nanometer to submicrometer size ranges
Asep Bayu Dani Nandiyanto et al.
ADVANCED POWDER TECHNOLOGY (2011)
The Airway Epithelium: Soldier in the Fight against Respiratory Viruses
Marjolaine Vareille et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
Matthew M. Hufford et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses
Lea Torrieri-Dramard et al.
MOLECULAR THERAPY (2011)
Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model
Savita Nair et al.
RETROVIROLOGY (2011)
New developments in dry powder pulmonary vaccine delivery
Tomas Sou et al.
TRENDS IN BIOTECHNOLOGY (2011)
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
Samuele Calabro et al.
VACCINE (2011)
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
Sandra Morel et al.
VACCINE (2011)
Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery
Sejin Son et al.
BIOMATERIALS (2010)
Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
Byoung-Shik Shim et al.
BMC IMMUNOLOGY (2010)
An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration
K. LÖVGREN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
An Intranasally Delivered Toll-Like Receptor 7 Agonist Elicits Robust Systemic and Mucosal Responses to Norwalk Virus-Like Particles
Lissette S. Velasquez et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Norwalk virus-like particles as vaccines
Melissa Herbst-Kralovetz et al.
EXPERT REVIEW OF VACCINES (2010)
Virus-like particles in vaccine development
Antonio Roldao et al.
EXPERT REVIEW OF VACCINES (2010)
Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects
Heidi M. Mansour et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses
Ling Ye et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Non-invasive Systemic Drug Delivery: Developability Considerations for Alternate Routes of Administration
Neil R. Mathias et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Intranasal Immunization with an Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery Formulation Protects against a Respiratory Pathogen Challenge
Girishchandra B. Patel et al.
PLOS ONE (2010)
Particle Size Influences the Immune Response Produced by Hepatitis B Vaccine Formulated in Inhalable Particles
Chandan Thomas et al.
PHARMACEUTICAL RESEARCH (2010)
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: Nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen
Bram Slutter et al.
VACCINE (2010)
Nanoparticles for nasal vaccination
Noemi Csaba et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
Michael Schotsaert et al.
EXPERT REVIEW OF VACCINES (2009)
Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response
Janet E. McElhaney
EXPERT REVIEW OF VACCINES (2009)
Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems
Sameer Sharma et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus
Rebekka Kohlmann et al.
JOURNAL OF VIROLOGY (2009)
Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge
Lucy A. Perrone et al.
JOURNAL OF VIROLOGY (2009)
Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice
Maytal Bivas-Benita et al.
VACCINE (2009)
Challenges in mucosal vaccination of cattle
P. E. Shewen et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2009)
Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates
Anna U. Bielinska et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes
Rogerio S. Rosada et al.
BMC IMMUNOLOGY (2008)
The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells
Anja Seubert et al.
JOURNAL OF IMMUNOLOGY (2008)
Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes
Lee A. Davies et al.
MOLECULAR THERAPY (2008)
Immunization by a bacterial aerosol
Lucila Garcia-Contreras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Archaeosome adjuvants: Immunological capabilities and mechanism(s) of action
Lakshmi Krishnan et al.
VACCINE (2008)
Airway epithelial cell signaling in response to bacterial pathogens
Marisa I. Gomez et al.
PEDIATRIC PULMONOLOGY (2008)
Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines
Girishchandra B. Patel et al.
VACCINE (2007)
Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1
Miyako Nagamachi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Pluronic® F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin
Mi Lan Kang et al.
VACCINE (2007)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization
WT Gao et al.
JOURNAL OF VIROLOGY (2006)
Pathogen recognition and development of particulate vaccines: Does size matter?
Sue D. Xiang et al.
METHODS (2006)
Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity
Martha Kalkanidis et al.
METHODS (2006)
Transfection efficiency and cytotoxicity of cationic liposomes in primary cultures of rainbow trout (Oncorhynchus mykiss) gill cells
K Romoren et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Characterization of viral agents causing acute respiratory infection in a San Francisco University medical center clinic during the influenza season
JK Louie et al.
CLINICAL INFECTIOUS DISEASES (2005)
PLA-PEG particles as nasal protein carriers:: the influence of the particle size
A Vila et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
HO Alpar et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
H Tamber et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Virus-like particles as carriers for T-cell epitopes: Limited inhibition of T-cell priming by carrier-specific antibodies
C Ruedl et al.
JOURNAL OF VIROLOGY (2005)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses
DQ Wang et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines
M Vajdy et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
The upper and lower respiratory respiratory tracts differ in their requirement of IFN-γ and IL-4 in controlling mycoplasma infection and disease
MD Woolard et al.
JOURNAL OF IMMUNOLOGY (2004)
PEG-PLA nanoparticles as carriers for nasal vaccine delivery
A Vila et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2004)
Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine
R Lambkin et al.
VACCINE (2004)
IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut
T Shikina et al.
JOURNAL OF IMMUNOLOGY (2004)
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
C Foged et al.
VACCINE (2004)
PEI -: a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice
K Regnström et al.
GENE THERAPY (2003)
Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice
IM van der Lubben et al.
VACCINE (2003)
Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccine
A Coulter et al.
VACCINE (2003)
Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro
HF Sun et al.
VACCINE (2003)
Mucosal immunity: Some historical perspective on host-pathogen interactions and implications for mucosal vaccines
PL Ogra
IMMUNOLOGY AND CELL BIOLOGY (2003)
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
NR Labiris et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Recent advances in mucosal vaccines and adjuvants
K Eriksson et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Role of upper and lower respiratory tract immunity in resistance to mycoplasma respiratory disease
LM Hodge et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Lung dendritic cells are primed by inhaled particulate antigens, and retain MHC class II/antigenic peptide complexes in hilar lymph nodes for a prolonged period of time
Q Vu et al.
IMMUNOLOGY (2002)
Design of biodegradable particles for protein delivery
A Vila et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Delivery technologies for human vaccines
P Moingeon et al.
BRITISH MEDICAL BULLETIN (2002)
Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization
HF Staats et al.
JOURNAL OF IMMUNOLOGY (2001)
Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses
RA Guerrero et al.
JOURNAL OF VIROLOGY (2001)
Chitosan as a novel nasal delivery system for vaccines
L Illum et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Nasal vaccination using live bacterial vectors
N Mielcarek et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands
SK Eo et al.
VACCINE (2001)
Tetanus toroid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): Evaluation of antibody response after oral and nasal application in mice
T Jung et al.
PHARMACEUTICAL RESEARCH (2001)
Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology
JA Wiley et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Vaccine delivery: lipid-based delivery systems
ME Baca-Estrada et al.
JOURNAL OF BIOTECHNOLOGY (2000)
Epidemiology and unique aspects of aging and infectious diseases
TT Yoshikawa
CLINICAL INFECTIOUS DISEASES (2000)
Stability of aluminium-containing adjuvants during aging at room temperature
LS Burrell et al.
VACCINE (2000)
Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant
R Gluck et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
